Sökning: "Per Malmström"

Visar resultat 1 - 5 av 11 avhandlingar innehållade orden Per Malmström.

  1. 1. Om konstens väsende och betydelse. Afhandling, som ... under inseende af mag. Pehr Daniel Amadeus Atterbom ... för filosofiska graden, författad och utgifven af af Bernhard Elis Malmström af Södemanlands och nerikes landskap. Stip. Jungblad., offentligen försvaras ... d. 3 junii 1842

    Författare :Per Daniel Amadeus Atterbom; Bernhard Elis Malmström; Per Daniel Amadeus Atterbom; Uppsala universitet; []
    Nyckelord :HUMANIORA; HUMANITIES;

    Sammanfattning : .... LÄS MER

  3. 2. Studies on rat and human lymphocytes separated in aqueous two-phase systems

    Författare :Per Malmström; Lund Wallenberglaboratoriet; []
    Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES;

    Sammanfattning : .... LÄS MER

  4. 3. Urinary Bladder Carcinoma – Studies of Outcome of Current Management and Experimental Therapy

    Författare :Truls Gårdmark; Per-Uno Malmström; Jörgen Carlsson; Sverker Hellsten; Willem Oosterlinck; Uppsala universitet; []
    Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Surgery; Bladder; Epidemiology; Administration; Intravesical; Radiotherapy; Kirurgi; Surgery; Kirurgi;

    Sammanfattning : The thesis concerns the epidemiology, current and possible future treatment of urothelial cancer of the urinary bladder. The Swedish National Quality Registry for Bladder Cancer 1997-2001 was used to explore epidemiology, current therapies and outcome. More common in men, the incidence for Ta and T1 tumours peaks in the age range 70-79 years. LÄS MER

  5. 4. Prognostic and Predictive Factors in Bladder Cancer

    Författare :Tammer Hemdan; Per-Uno Malmström; Ulrika Segersten; Peter Boström; Uppsala universitet; []
    Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; bladder cancer; BCG; cisplatin; STMN1; emmprin; survivin; CCTα; biomarker; immunohistochemistry; IHC; tissue microarray; TMA;

    Sammanfattning : Bladder cancer is a potentially curable malignancy; however in regards to the state of current therapy regimens, a plateau has been reached in both the non-muscle and muscle invasive types. To obtain effective treatment, and consequently a decreased mortality, it has become imperative to test and understand aspects affecting therapy response. LÄS MER

  7. 5. Hypoxia inducible factor-1α in renal cell carcinoma

    Författare :Anders Lidgren; Börje Ljungberg; Torgny Rasmuson; Kjell Grankvist; Anders Bergh; Per-Uno Malmström; Umeå universitet; []
    Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; renal cell carcinoma; hypoxia; RT-PCR; angiogenesis; western blot; tissue microarray; protein; mRNA; HIF-1 alpha; GLUT-1; survival; Urology and andrology; Urologi och andrologi;

    Sammanfattning : Hypoxia Inducible Factor-1α in Renal Cell Carcinoma Departments of Surgical and Perioperative Sciences, Urology and Andrology; Radiation Sciences, Oncology; Medical Biosciences, Pathology; and Medical Biosciences, Clinical Chemistry, Umeå University, Umeå, Sweden Background: Renal cell carcinoma (RCC) accounts for approximately 2-3% of all human cancers. A distinguished feature of RCC is vascularisation and among the three dominating RCC types conventional RCC (cRCC) generally is more vascularised than papillary RCC (pRCC) and chromophobe RCC (chRCC). LÄS MER